中文 | English
Return
Total: 10 , 1/1
Show Home Prev Next End page: GO
Author:(Xuefen CAO)

1.Reasons for Quarantined Patients' Incomplete Obedience to Medical Order and Countermeasures

Xuefen GU ; Lan ZHANG ; Shuqin CAO

Chinese Medical Ethics 1994;0(06):-

2.The study of mode and effect of cognitive-behavioral therapy for lung transplant recipients during waiting for lung

Xiaodong CAO ; Yunjuan HUANG ; Tingli ZHU ; Xuefen ZHU ; Ye DING ; Jingyu CHEN ; Xiaomin REN ; Haiqin ZHOU

Chinese Journal of Practical Nursing 2012;(35):75-78

3.Analysis of contact allergens in 1065 patients with dermatitis or eczema in Wuxi city

Yan HU ; Xunyi DAI ; Lei CAO ; Xuefen LU ; Juan ZHANG ; Ying FAN ; Aifen ZHOU ; Lijia YANG

Chinese Journal of Dermatology 2012;45(10):747-749

4.Role of histone deacetylase 6 in reduction of intestinal ischemia-reperfusion injury by sodium butyrate in mice

Xingjiao LYU ; Yufang LENG ; Xiaoxia HAN ; Xiaoyu HOU ; Xuefen CAO ; Janvier NIBARUTA

Chinese Journal of Anesthesiology 2022;42(6):690-694

5.Role of histone deacetylase in sodium butyrate-induced reduction of intestinal ischemia-reperfusion injury in mice: relationship with oxidative stress and cell apoptosis

Xiaoxia HAN ; Yufang LENG ; Xingjiao LYU ; Xiaoyu HOU ; Xuefen CAO ; Janvier NIBARUTA

Chinese Journal of Anesthesiology 2022;42(8):957-960

6. Tetramethylpyrazine protected against intestinal ischemia-reperfusion injury induced pyroptosis by inhibiting NLRP3 inflammasome activation

Xuefen CAO ; Yufang LENG ; Xiaoxia HAN ; Xiaoyu HOU ; Xingjiao LYU ; Janvier NIBARUTA ; Xuefen CAO ; Yufang LENG

Chinese Journal of Clinical Pharmacology and Therapeutics 2023;28(11):1201-1208

7. Research progress on the role and mechanism of irisin in organ ischemia/ reperfusion injury

Xiaoxia HAN ; Yufang LENG ; Xingjiao LV ; Xiaoyu HOU ; Xuefen CAO ; Janvier NIBARUTA ; Yufang LENG

Chinese Journal of Clinical Pharmacology and Therapeutics 2022;27(8):886-891

8. Research progress of short-chain fatty acids in alleviating organ ischemia-reperfusion injury

Xingjiao LV ; Yufang LENG ; Xiaoxia HAN ; Xiaoyu HOU ; Xuefen CAO ; Janvier NIBARUTA ; Yongqiang LIU ; Yufang LENG

Chinese Journal of Clinical Pharmacology and Therapeutics 2022;27(2):219-226

9. Research Progress on Role and Mechanism of Butyrate in Intestinal Diseases

Xiaoxia HAN ; Yufang LENG ; Xingjiao LÜ ; Xiaoyu HOU ; Xuefen CAO ; Janvier NIBARUTA ; Yufang LENG

Chinese Journal of Gastroenterology 2022;27(3):187-190

10. Network analysis and experimental verification of  Schisandrin B reduces intestinal ischemia reperfusion injury

Xiaoyu HOU ; Yufang LENG ; Xuefen CAO ; Xingjiao LV ; Xiaoxia HAN ; Janvier NIBARUTA ; Yongqiang LIU ; Yufang LENG ; Yongqiang LIU

Chinese Journal of Clinical Pharmacology and Therapeutics 2023;28(2):147-154

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 10 , 1/1 Show Home Prev Next End page: GO